Issue Date | 17-Nov-2015 | Prospectus | n/a |
Issue Price | n/a | Lead Broker | n/a |
Market Cap | £0.00m | Contact Tel | +44 203 440 5654 |
Method | Introduction | ||
Sector | Pharmaceuticals | ||
Market | Aim | ||
Amount Raised | £0.00m |
Currency | UK Pounds |
Share Price | 228.00p |
Change Today | -7.00p |
% Change | -2.98 % |
52 Week High | 250.00 |
52 Week Low | 92.50 |
Volume | 7,918 |
Shares Issued | 111.60m |
Market Cap | £254.45m |
Beta | 0.03 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 1 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
16:35 | 301 @ 228.00p |
16:35 | 1 @ 228.00p |
16:35 | 300 @ 228.00p |
12:12 | 500 @ 235.00p |
10:37 | 300 @ 235.10p |
CFO | Yrjö E K Wichmann |
CEO | Juho Jalkanen |
Chair | Tuomo Pätsi |
You are here: research